Prasugrel Tablet, Film Coated
Product Images NDC 0378-5186
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Prasugrel (NDC 0378-5186). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Prasugrel Hydrochloride Structural Formula (Image 02)
Figure 2: Inhibition (mean ± Sd) Of 20 μm Adp-induced Platelet Aggregation (ipa) Measured By Light Transmission Aggregometry After Prasugrel 60 mg. (Image 03)
Figure 3: Time To First Event Of Cv Death, Mi, Or Stroke (triton-timi 38). (Image 04)
Figure 4: Subgroup Analyses For Time To First Event Of Cv Death, Mi, Or Stroke (hr And 95% Ci; Triton-timi 38) – Ua/nstemi Patients. (Image 05)
Figure 5: Subgroup Analyses For Time To First Event Of Cv Death, Mi, Or Stroke (hr And 95% Ci; Triton-timi 38) – Stemi Patients. (Image 06)
Prasugrel Tablets 5 mg Bottle Label (Image 07)
Prasugrel Tablets 10 mg Bottle Label (Image 08)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.